Showing results (341-350 of 1,607) with videos related to
Sort By:
Pageof 161
JAMA Oncology|January 22, 2026
Cost-Effectiveness of Adjuvant Immunotherapy in Cancer Treatments: A Systematic ReviewRashidul Alam Mahumud, Yifu Chen, Md Shahjalal, et al.JAMA Oncology|November 13, 2025
Immune Checkpoint Inhibitor-Associated Cardiovascular Toxic Effects: International Cardio-Oncology Society Position StatementJoerg Herrmann, Ana Barac, Joseph Carver, et al.JAMA Oncology|December 26, 2025
Baseline Fatigue and Severe Toxic Effects in Patients With Cancer Receiving Systemic TherapyJoseph M Unger, Michael J Fisch, Salene M W Jones, et al.JAMA Oncology|November 13, 2025
Ultraprocessed Food Consumption and Risk of Early-Onset Colorectal Cancer Precursors Among WomenChen Wang, Mengxi Du, Hanseul Kim, et al.JAMA Oncology|June 26, 2025
High-Dose Aumolertinib for Untreated EGFR-Variant Non-Small Cell Lung Cancer With Brain Metastases: The ACHIEVE Phase 2 Nonrandomized Clinical TrialHui Li, Kaiyan Chen, Lei Gong, et al.JAMA Oncology|July 3, 2025
First-Line Therapy For Advanced Non-Clear Cell Renal Cell Carcinoma: A Systematic Review and Meta-AnalysisFausto Petrelli, Elena Verri, Antonio Ghidini, et al.JAMA Oncology|September 18, 2025
Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With Advanced Penile Cancer: The Nonrandomized HERCULES (LACOG 0218) Clinical TrialFernando Cotait Maluf, Karine Trindade, Daniel Preto, et al.JAMA Oncology|May 22, 2025
Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non-Small Cell Lung CancerBiagio Ricciuti, Francesca Fusco, Alissa Cooper, et al.JAMA Oncology|June 1, 2025
Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials: A Meta-Epidemiological AnalysisAlexander D Sherry, Avital M Miller, Jnana Preeti Parlapalli, et al.JAMA Oncology|June 5, 2025
Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols: A Secondary Analysis of 3 Clinical TrialsSamer Al Hadidi, Obada Ehab Ababneh, Carolina D Schinke, et al.Pageof 161